EE9900588A - CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral - Google Patents

CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral

Info

Publication number
EE9900588A
EE9900588A EEP199900588A EEP9900588A EE9900588A EE 9900588 A EE9900588 A EE 9900588A EE P199900588 A EEP199900588 A EE P199900588A EE P9900588 A EEP9900588 A EE P9900588A EE 9900588 A EE9900588 A EE 9900588A
Authority
EE
Estonia
Prior art keywords
graft
compositions
methods
blockade
insulin
Prior art date
Application number
EEP199900588A
Other languages
English (en)
Estonian (et)
Inventor
S. Kenyon Norma
Ricordi Camillo
W. Thomas David
Burkly Linda
Original Assignee
Biogen, Incorporated
University Of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Incorporated, University Of Miami filed Critical Biogen, Incorporated
Publication of EE9900588A publication Critical patent/EE9900588A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • External Artificial Organs (AREA)
  • Steroid Compounds (AREA)
EEP199900588A 1997-06-20 1998-06-19 CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral EE9900588A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5026797P 1997-06-20 1997-06-20
US7726598P 1998-03-09 1998-03-09
PCT/US1998/012892 WO1998058669A2 (fr) 1997-06-20 1998-06-19 Therapie de blocage par cd154 pour transplantation de tissus d'ilots pancreatiques

Publications (1)

Publication Number Publication Date
EE9900588A true EE9900588A (et) 2000-08-15

Family

ID=26728084

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900588A EE9900588A (et) 1997-06-20 1998-06-19 CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral

Country Status (22)

Country Link
US (2) US20030072754A1 (fr)
EP (1) EP1051191B1 (fr)
JP (1) JP2002506446A (fr)
KR (1) KR100634847B1 (fr)
CN (2) CN1195546C (fr)
AT (1) ATE339966T1 (fr)
AU (1) AU730763B2 (fr)
BG (1) BG64976B1 (fr)
BR (1) BR9810620A (fr)
CA (1) CA2294154A1 (fr)
DE (1) DE69835965T2 (fr)
EA (1) EA002550B1 (fr)
EE (1) EE9900588A (fr)
HK (1) HK1033548A1 (fr)
HU (1) HUP0003160A3 (fr)
IL (1) IL133303A0 (fr)
IS (1) IS5273A (fr)
NO (1) NO996275L (fr)
NZ (1) NZ502052A (fr)
SK (1) SK180299A3 (fr)
TR (1) TR199903142T2 (fr)
WO (1) WO1998058669A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045958A1 (fr) * 1998-03-09 1999-09-16 Biogen, Inc. Therapie de blocage du cd154 pour la modulation des reponses immunes aux implants
WO2001079555A2 (fr) 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles des membres de la famille jak/stat dans l'induction de la tolerance
CA2410786A1 (fr) * 2000-06-02 2001-12-13 Regents Of The University Of Minnesota Procede immunotherapeutique permettant de prevenir le rejet de cellules insulaires
KR20030007899A (ko) * 2000-06-09 2003-01-23 브리스톨-마이어스스퀴브컴파니 림프구성 신호의 차단 및 ｌｆａ-1 매개 접착의 차단을통한 세포-매개 면역 반응의 조절 방법
CA2528551A1 (fr) * 2003-06-13 2005-01-13 Biogen Idec Ma Inc. Anticorps d'aglycosyle anti-cd154 (ligand cd40) et utilisations correspondantes
AU2005287406B2 (en) 2004-07-26 2011-08-18 Biogen Ma Inc. Anti-CD154 antibodies
JP2008520235A (ja) * 2004-11-22 2008-06-19 ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド インスリンを産生可能な拡大され、かつ再分化した成体島β細胞の集団およびその作製方法
WO2007047539A2 (fr) * 2005-10-14 2007-04-26 Medtronic, Inc. Administration localisee au systeme lymphatique
US8372399B2 (en) 2006-08-31 2013-02-12 Cardiac Pacemakers, Inc. Bispecific antibodies and agents to enhance stem cell homing
US8636995B2 (en) 2006-08-31 2014-01-28 Cardiac Pacemakers, Inc. Methods and devices to regulate stem cell homing
WO2010093467A1 (fr) * 2009-02-10 2010-08-19 The Trustees Of Columbia University In The City Of New York Méthodes pour induire une tolérance à la transplantation
WO2011146395A2 (fr) 2010-05-17 2011-11-24 The Board Of Trustees Of The Leland Stanford Junior University Prévention de rejet immunologique de cellules souches transplantées par blocage de molécule costimulante de leucocyte
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
US10147463B2 (en) 2014-12-10 2018-12-04 Nxp Usa, Inc. Video processing unit and method of buffering a source video stream
US9512229B2 (en) 2015-03-03 2016-12-06 Kymab Limited Synergistic combinations of OX40L antibodies for the treatment of GVHD
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
US10986309B2 (en) 2015-06-30 2021-04-20 Nxp Usa, Inc. Video buffering and frame rate doubling device and method
EP3534947A1 (fr) 2016-11-03 2019-09-11 Kymab Limited Anticorps, combinaisons comprenant des anticorps, biomarqueurs, utilisations et procédés
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5474771A (en) * 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US5683693A (en) * 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
WO1997034633A1 (fr) * 1996-03-20 1997-09-25 Bristol-Myers Squibb Company Procedes d'inhibition d'une reponse immune par blocage des voies de gp39/cd40 et ctla4/cd28/b7 et compositions utilisees avec ceux-ci

Also Published As

Publication number Publication date
BR9810620A (pt) 2000-10-03
HUP0003160A3 (en) 2002-09-30
US20030072754A1 (en) 2003-04-17
NZ502052A (en) 2001-01-26
CN1195546C (zh) 2005-04-06
HK1033548A1 (en) 2001-09-07
KR20010013965A (ko) 2001-02-26
IS5273A (is) 1999-11-26
CN1651919A (zh) 2005-08-10
NO996275L (no) 2000-02-21
EA200000058A1 (ru) 2000-08-28
EP1051191A2 (fr) 2000-11-15
KR100634847B1 (ko) 2006-10-17
CA2294154A1 (fr) 1998-12-30
AU730763B2 (en) 2001-03-15
BG104091A (en) 2000-10-31
HUP0003160A2 (hu) 2001-01-29
CN1261286A (zh) 2000-07-26
EP1051191B1 (fr) 2006-09-20
DE69835965T2 (de) 2007-06-14
JP2002506446A (ja) 2002-02-26
EA002550B1 (ru) 2002-06-27
IL133303A0 (en) 2001-04-30
WO1998058669A2 (fr) 1998-12-30
BG64976B1 (bg) 2006-11-30
AU7983098A (en) 1999-01-04
NO996275D0 (no) 1999-12-17
WO1998058669A3 (fr) 1999-04-29
ATE339966T1 (de) 2006-10-15
TR199903142T2 (xx) 2000-09-21
DE69835965D1 (de) 2006-11-02
US20070292440A1 (en) 2007-12-20
SK180299A3 (en) 2000-06-12

Similar Documents

Publication Publication Date Title
EE9900588A (et) CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral
ATE482717T1 (de) Peptid yy (pyy) zur behandlung von glukose stoffwechselkrankheiten
DK1066052T3 (da) Mesenchymstamceller til forebyggelse og behandling af immunreaktioner ved transplantationer
DK1220611T3 (da) Suppressorceller til forebyggelse og behandling af immunreaktioner ved transplantation
NZ515718A (en) Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
DE60110054D1 (en) Cardioprotektive phosphonate
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
WO2003102162A3 (fr) Nouvelles cellules dendritiques tolerogeniques et utilisations therapeutiques de celles-ci
WO1993006852A3 (fr) Procede d'amelioration de la tolerance d'allogreffes ou de xenogreffes par administration d'une proteine de liaison de lfa-3 ou de cd2
CA2119236A1 (fr) Utilisation d'ifn-gamma pour le traitement des infections chez les receveurs de greffes
GR900100535A (en) Substituted 2-imidazolines and preparation and use thereof
EP1754490A3 (fr) Thérapie de blocage par CD154 pour transplantation de tissus d'ilots pancréatiques chez les primates
DE69231583D1 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
UA32295A (uk) Спосіб лікування порушень фертильності у хворих на цукровий діабет
EP0886528A4 (fr) Utilisation de bacteries coxiella pour traiter des maladies auto-immunes
WO2001051093A3 (fr) METHODES PERMETTANT D'AUGMENTER LA SENSIBILITE AU GLUCOSE DES LYMPHOCYTES PANCREATIQUES $g(b)
CA2402489A1 (fr) Induction de tolerance orale grace a du collagene, afin de prevenir le rejet d'une allogreffe
ATE283063T1 (de) Allogene und xenogene transplantation
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC1A Change of owner name